General Information of the Compound
| Compound ID |
CP0438513
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-(9,10-Dihydro-anthracen-9-yl)-propylamine
Show/Hide
|
||||||||||||||||||
| Synonyms |
9,10-dihydroanthracene(DHA), 3a
9-(2-aminopropyl)-9,10-dihydroanthracene
9-(3-Aminopropyl)-9,10-dihydroanthracene
BDBM35926
CHEMBL158780
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H19N
|
||||||||||||||||||
| Molecular Weight |
237.346
|
||||||||||||||||||
| Canonical SMILES |
NCCCC1c2ccccc2Cc2ccccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H19N/c18-11-5-10-17-15-8-3-1-6-13(15)12-14-7-2-4-9-16(14)17/h1-4,6-9,17H,5,10-12,18H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
AUTKMGMMFJXIDV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound